Skip to content
value.today

Denovo Sciences, Inc.

🇺🇸 Plymouth, Michigan, USAHealth CareFounded 2013
Total raised
$32 M
6 rounds on record
Latest round
$19 M
Nov 2018
First round on record
Nov 2013
Today
Private
No later event on record

Funding rounds

6 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Denovo Sciences, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2018$19 MNo. 6$10 to $50 million

Denovo Sciences, Inc.: Raise no. 6, Nov 2018

Investors in this round

44 investors had bought by the notice of Nov 26, 2018: 44 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$19 M of $22 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • John Stark · Executive Officer, Director
  • Kalyan Handique · Executive Officer, Director
  • Gregg Fergus · Director
  • Jack Ball · Director
  • John Miller · Director
  • Roger Newton · Director
  • Walter Young, Jr. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by John Stark, Ceo. Source: SEC Form D, newest notice filed Nov 26, 2018. Read the notice at the SEC.

equity, optionsSEC
Oct 2017$8 MNo. 5$2 to $10 million

Denovo Sciences, Inc.: Raise no. 5, Oct 2017

Investors in this round

40 investors had bought by the notice of Oct 26, 2017: 40 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$8 M of $8 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kalyan Handique · Executive Officer, Director
  • Priyardarshini Gogoi · Executive Officer, Director
  • Jack Ball · Director
  • John Miller · Director
  • Roger Newton · Director
  • Walter Young, Jr. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kalyan Handique, President. Source: SEC Form D, newest notice filed Oct 26, 2017. Read the notice at the SEC.

equitySEC
Sep 2016$2 MNo. 4Under $2 million

Denovo Sciences, Inc.: Raise no. 4, Sep 2016

Investors in this round

23 investors had bought by the notice of Sep 23, 2016: 23 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $4 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kalyan Handique · Executive Officer, Director
  • Priyardarshini Gogoi · Executive Officer, Director
  • Jack Ball · Director
  • Roger Newton · Director
  • Walter Young, Jr. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kalyan Handique, President. Source: SEC Form D, newest notice filed Sep 23, 2016. Read the notice at the SEC.

debt, optionsSEC
Sep 2015$1 MNo. 3Under $2 million

Denovo Sciences, Inc.: Raise no. 3, Sep 2015

Investors in this round

19 investors had bought by the notice of Sep 24, 2015: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $3 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kalyan Handique · Executive Officer, Director
  • Priyardarshini Gogoi · Executive Officer, Director
  • Dr. David Parkinson · Director
  • Jack Ball · Director
  • Roger Newton · Director
  • Walter Young, Jr. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kalyan Handique, President. Source: SEC Form D, newest notice filed Sep 24, 2015. Read the notice at the SEC.

debt, optionsSEC
Oct 2014$2 MNo. 2$2 to $10 million

Denovo Sciences, Inc.: Raise no. 2, Oct 2014

Investors in this round

21 investors had bought by the notice of Dec 5, 2014: 21 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kalyan Handique · Executive Officer, Director
  • Priyardarshini Gogoi · Executive Officer, Director
  • Dr. David Parkinson · Director
  • Timothy Mayleben · Director
  • Walter Young, Jr. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kalyan Handique, President & CEO. Source: SEC Form D and 1 amendment, newest notice filed Dec 5, 2014. Read the notice at the SEC.

equitySEC
Nov 2013$1 MNo. 1Under $2 million

Denovo Sciences, Inc.: Raise no. 1, Nov 2013

Investors in this round

17 investors had bought by the notice of Nov 27, 2013: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $1 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Kalyan Handique · Executive Officer, Director
  • Priyadarshini Gogoi · Executive Officer, Director
  • Tim Mayleben · Director
  • Walter Young, Jr. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Kalyan Handique, President. Source: SEC Form D, newest notice filed Nov 27, 2013. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Denovo Sciences, Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2018).

    SEC Form D · Nov 2018

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Nov 2018

That is all the official record says: Denovo Sciences, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Denovo Sciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 6 rounds above had up to 44 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Denovo Sciences, Inc.
NameRoleNamed in
John StarkExecutive officerNov 2018
Kalyan HandiqueExecutive officerNov 2018
Priyardarshini GogoiExecutive officerOct 2017
Priyadarshini GogoiExecutive officerNov 2013
Gregg FergusDirectorNov 2018
Jack BallDirectorNov 2018
John MillerDirectorNov 2018
John StarkDirectorNov 2018
Kalyan HandiqueDirectorNov 2018
Roger NewtonDirectorNov 2018
Walter Young, Jr.DirectorNov 2018
Priyardarshini GogoiDirectorOct 2017
Dr. David ParkinsonDirectorSep 2015
Timothy MaylebenDirectorDec 2014
Priyadarshini GogoiDirectorNov 2013
Tim MaylebenDirectorNov 2013